Real-World Comparative Effectiveness Study of TYVASO (Inhaled Treprostinil) in the Treatment of PH-ILD

First published 12/04/2024

Last updated 19/08/2025

EU PAS number:

EUPAS1000000109

Study

Ongoing

Documents

Study protocol

Initial protocol

Ferrer_PH-ILD_TYVASO_Protocol_V1.0_Signed_19JAN2024.pdf

English (1.05 MB - PDF) View document

Updated protocol

Ferrer_PH-ILD_TYVASO_ECA_protocol_v2.0_09072024_signed.pdf

First published: 22/07/2024

English (2.06 MB - PDF) View document

Study results

Real-World Comparative Effectiveness Study of TYVASO-Inhaled Treprostinil- in the Treatment of PH-ILD study Abstract.pdf

English (974.4 KB - PDF) View document

Study report

Other information

Secondary tabs